Transient pre-baseline antipsychotic exposure (TPAE) is a prognostic specifier in clinical high risk for psychosis: evidence from the PSYSCAN consortium study

Andrea Raballo, Michele Poletti, Antonio Preti

Open source

DOI
10.1038/s41537-025-00665-3
Published
2025-09-26
Container
Schizophrenia
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41537-025-00665-3,
  title = {Transient pre-baseline antipsychotic exposure (TPAE) is a prognostic specifier in clinical high risk for psychosis: evidence from the PSYSCAN consortium study},
  author = {Andrea Raballo and Michele Poletti and Antonio Preti},
  year = {2025},
  journal = {Schizophrenia},
  doi = {10.1038/s41537-025-00665-3},
  url = {https://doi.org/10.1038/s41537-025-00665-3}
}

RIS

TY  - JOUR
TI  - Transient pre-baseline antipsychotic exposure (TPAE) is a prognostic specifier in clinical high risk for psychosis: evidence from the PSYSCAN consortium study
AU  - Andrea Raballo
AU  - Michele Poletti
AU  - Antonio Preti
PY  - 2025
JO  - Schizophrenia
DO  - 10.1038/s41537-025-00665-3
UR  - https://doi.org/10.1038/s41537-025-00665-3
ER  - 

APA

Raballo, A., Poletti, M., & Preti, A. (2025). Transient pre-baseline antipsychotic exposure (TPAE) is a prognostic specifier in clinical high risk for psychosis: evidence from the PSYSCAN consortium study. Schizophrenia. https://doi.org/10.1038/s41537-025-00665-3

Source records